5 Results for "

estrogen-deficient

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "estrogen-deficient" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-N7501
CAS No.: 486-63-5
Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions .
loading...
    loading...
Cat. No.: HY-N7501R
CAS No.: 486-63-5
Isoformononetin (Standard) is the analytical standard of Isoformononetin. This product is intended for research and analytical applications. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions .
loading...
    loading...
Cat. No.: HY-N7501S
Isoformononetin-d3 is the deuterium labeled Isoformononetin (HY-N7501). Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions .
loading...
    loading...
Cat. No.: HY-135592
CAS No.: 63675-88-7
Target:  

Estrogen Receptor/ERR

Research Areas:  

Endocrinology

LY88074 Methyl ether (Example 2) is useful for the inhibition of the various estrogen deficient conditions, which are associated with estrogendeprivation syndrome including osteoporosis and hyperlipidemia .
loading...
    loading...
Cat. No.: HY-135583
CAS No.: 63675-87-6
Target:  

Estrogen Receptor/ERR

Research Areas:  

Endocrinology

LY88074 Trimethyl ether (Example 1) is useful for the inhibition of the various estrogen deficient conditions, which are associated with estrogen deprivation syndrome including osteoporosis and hyperlipidemia .
loading...
    loading...